Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-23T22:02:11.108Z Has data issue: false hasContentIssue false
  • English
  • Français

Exogenous NGF Affects Cholinergic Transmitter Function and Y-Maze Behavior in Aged Fischer 344 Male Rats

Published online by Cambridge University Press:  18 September 2015

Lawrence R. Williams ,
R. Jane Rylett ,
Hylan C. Moises  and
Andrew H. Tang
Lawrence R. Williams*
Affiliation:
CNS Diseases Research, The Upjohn Company, Kalamazoo
R. Jane Rylett
Affiliation:
Department of Physiology, University of Western Ontario and The Robart's Research Institute, London
Hylan C. Moises
Affiliation:
Department of Physiology, University of Michigan, Ann Arbor
Andrew H. Tang
Affiliation:
CNS Diseases Research, The Upjohn Company, Kalamazoo
*
CNS Diseases Research, Unit 7251-209-5, The Upjohn Company, 301 Henrietta Street, Kalamazoo, Michigan, U.S.A. 49001
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Chronic ICV administration of NGF stimulates the activity of the cholinergic neuronal markers, HACU and ChAT, as well as the evoked release of both endogenous and newly synthesized acetylcholine in the brain of aging Fischer 344 male rats. However, the pattern of cholinergic phenotype stimulation indicates an age-related differential regulation of ChAT, HACU, and ACh release between specific brain areas, with the largest.effects found in the striatum. NGF treatment also increases the effectiveness of neurotransmission between basal forebrain cholinergic neurons and postsynaptic amygdaloid target neurons. The stimulation of central cholinergic transmitter function after NGF treatment affects behavior in a Y-maze brightness discrimination paradigm. NGF treatment does not affect the cognitive measure of brightness discrimination, but reduces the number of avoidance attempts, a measure of motor function.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 18 , Issue S3 , August 1991 , pp. 403 - 407
Copyright
Copyright © Canadian Neurological Sciences Federation 1991

References

REFERENCES

1.Whittemore, SR, Seiger, Å. The expression, localization and func-tional significance of ?-nerve growth factor in the central nervous system. Brain Res Rev 1987; 12: 439–464.CrossRefGoogle Scholar
2.Williams, LR. Exogenous nerve growth factor stimulates choline acetyltransferase activity in aging Fischer 344 male rats. Neurobiol Aging 1990; in press.Google Scholar
3.Williams, LR, Jodelis, KS, Donald, MR. Axotomy-dependent stimu-lation of choline acetyltransferase by exogenous mouse nerve growth factor in rat basal forebrain. Brain Res 1989; 498: 243–256.CrossRefGoogle Scholar
4.Katzman, R. Alzheimer’s disease. N Eng J Med 1986; 314: 964–973.CrossRefGoogle ScholarPubMed
5.Williams, LR, Rylett, RJ. Exogenous nerve growth factor increases the activity of high affinity choline uptake and choline acetyl-transferase in the brain of Fischer 344 male rats. J Neurochem 1990; 55: 1042–1049.CrossRefGoogle Scholar
6.Williams, LR, Varon, S, Peterson, GM, et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transection. Proc Nat Acad Sci (USA) 1986; 83: 9231–9235.CrossRefGoogle ScholarPubMed
7.Hefti, F, Weiner, WJ. Nerve growth factor and Alzheimer’s disease. Ann Neurol 1986; 20: 275–281.CrossRefGoogle ScholarPubMed
8.Phelps, CH, Gage, FH, Growdon, JH, et al. Potential use of nerve growth factor to treat Alzheimer’s disease. Neurobiol Aging 1989; 10: 205–207.CrossRefGoogle ScholarPubMed
9.Williams, LR, Vahlsing, HL, Lindamood, T, et al. A small gauge can-nula device for continuous infusion of exogenous agents into the brain. Exp Neurol 1987; 95: 743–754.CrossRefGoogle Scholar
10.Israel, M, Lesbats, B. Application to mammalian tissues of the chemiluminescent method for detecting acetylcholine. J Neurochem 1982; 39: 248–250.CrossRefGoogle ScholarPubMed
11.Meyer, EM, Cooper, JR. Correlations between Na+-K+ ATPase activity and acetylcholine release in rat cortical synaptosomes. J Neurochem 1981; 36: 467–475.CrossRefGoogle ScholarPubMed
12.Washburn, MS, Moises, HC. Muscarinic responses of basolateral and lateral amygdaloid neurons recorded in vitro. Soc Neurosci Abstr 1989; 15: 525.Google Scholar
13.Tang, AH, Franklin, SR. Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats. J Pharmacol Exp Therap 1983; 225: 503–508.Google Scholar
14.Fischer, W, Wictorin, K, Björklund, A, et al. Intracerebral infusion of Nerve Growth Factor ameliorates cholinergic neuron atrophy and spatial memory impairments in aged rats. Nature 1987; 329: 65–68.CrossRefGoogle ScholarPubMed
15.Mandel, RJ, Gage, FH, Thai, LJ. Spatial learning in rats: Correlation with cortical choline acetyltransferase and improvement with NGF following NBM damage. Exp Neurol 1989; 104: 208–217.CrossRefGoogle ScholarPubMed
16.Anisman, H. Cholinergic mechanisms and alterations in behavioral suppression as factors producing time-dependent changes in avoidance performance. J Comp Physiol Psychol 1973; 83: 465–477.CrossRefGoogle ScholarPubMed
17.Harbaugh, RE, Reeder, TM, Senter, HJ, et al. Intracerebroventricular bethanechol chloride infusion in Alzheimer’s disease. J Neurosurg 1989; 71: 481–486.CrossRefGoogle ScholarPubMed